261 related articles for article (PubMed ID: 28440815)
1. 15q11.2 CNV affects cognitive, structural and functional correlates of dyslexia and dyscalculia.
Ulfarsson MO; Walters GB; Gustafsson O; Steinberg S; Silva A; Doyle OM; Brammer M; Gudbjartsson DF; Arnarsdottir S; Jonsdottir GA; Gisladottir RS; Bjornsdottir G; Helgason H; Ellingsen LM; Halldorsson JG; Saemundsen E; Stefansdottir B; Jonsson L; Eiriksdottir VK; Eiriksdottir GR; Johannesdottir GH; Unnsteinsdottir U; Jonsdottir B; Magnusdottir BB; Sulem P; Thorsteinsdottir U; Sigurdsson E; Brandeis D; Meyer-Lindenberg A; Stefansson H; Stefansson K
Transl Psychiatry; 2017 Apr; 7(4):e1109. PubMed ID: 28440815
[TBL] [Abstract][Full Text] [Related]
2. CNVs conferring risk of autism or schizophrenia affect cognition in controls.
Stefansson H; Meyer-Lindenberg A; Steinberg S; Magnusdottir B; Morgen K; Arnarsdottir S; Bjornsdottir G; Walters GB; Jonsdottir GA; Doyle OM; Tost H; Grimm O; Kristjansdottir S; Snorrason H; Davidsdottir SR; Gudmundsson LJ; Jonsson GF; Stefansdottir B; Helgadottir I; Haraldsson M; Jonsdottir B; Thygesen JH; Schwarz AJ; Didriksen M; Stensbøl TB; Brammer M; Kapur S; Halldorsson JG; Hreidarsson S; Saemundsen E; Sigurdsson E; Stefansson K
Nature; 2014 Jan; 505(7483):361-6. PubMed ID: 24352232
[TBL] [Abstract][Full Text] [Related]
3. Association of Copy Number Variation of the 15q11.2 BP1-BP2 Region With Cortical and Subcortical Morphology and Cognition.
; van der Meer D; Sønderby IE; Kaufmann T; Walters GB; Abdellaoui A; Ames D; Amunts K; Andersson M; Armstrong NJ; Bernard M; Blackburn NB; Blangero J; Boomsma DI; Brodaty H; Brouwer RM; Bülow R; Cahn W; Calhoun VD; Caspers S; Cavalleri GL; Ching CRK; Cichon S; Ciufolini S; Corvin A; Crespo-Facorro B; Curran JE; Dalvie S; Dazzan P; de Geus EJC; de Zubicaray GI; de Zwarte SMC; Delanty N; den Braber A; Desrivieres S; Di Forti M; Doherty JL; Donohoe G; Ehrlich S; Eising E; Espeseth T; Fisher SE; Fladby T; Frei O; Frouin V; Fukunaga M; Gareau T; Glahn DC; Grabe HJ; Groenewold NA; Gústafsson Ó; Haavik J; Haberg AK; Hashimoto R; Hehir-Kwa JY; Hibar DP; Hillegers MHJ; Hoffmann P; Holleran L; Hottenga JJ; Hulshoff Pol HE; Ikeda M; Jacquemont S; Jahanshad N; Jockwitz C; Johansson S; Jönsson EG; Kikuchi M; Knowles EEM; Kwok JB; Le Hellard S; Linden DEJ; Liu J; Lundervold A; Lundervold AJ; Martin NG; Mather KA; Mathias SR; McMahon KL; McRae AF; Medland SE; Moberget T; Moreau C; Morris DW; Mühleisen TW; Murray RM; Nordvik JE; Nyberg L; Olde Loohuis LM; Ophoff RA; Owen MJ; Paus T; Pausova Z; Peralta JM; Pike B; Prieto C; Quinlan EB; Reinbold CS; Reis Marques T; Rucker JJH; Sachdev PS; Sando SB; Schofield PR; Schork AJ; Schumann G; Shin J; Shumskaya E; Silva AI; Sisodiya SM; Steen VM; Stein DJ; Strike LT; Tamnes CK; Teumer A; Thalamuthu A; Tordesillas-Gutiérrez D; Uhlmann A; Úlfarsson MÖ; van 't Ent D; van den Bree MBM; Vassos E; Wen W; Wittfeld K; Wright MJ; Zayats T; Dale AM; Djurovic S; Agartz I; Westlye LT; Stefánsson H; Stefánsson K; Thompson PM; Andreassen OA
JAMA Psychiatry; 2020 Apr; 77(4):420-430. PubMed ID: 31665216
[TBL] [Abstract][Full Text] [Related]
4. 15q11.2 microdeletion (BP1-BP2) and developmental delay, behaviour issues, epilepsy and congenital heart disease: a series of 52 patients.
Vanlerberghe C; Petit F; Malan V; Vincent-Delorme C; Bouquillon S; Boute O; Holder-Espinasse M; Delobel B; Duban B; Vallee L; Cuisset JM; Lemaitre MP; Vantyghem MC; Pigeyre M; Lanco-Dosen S; Plessis G; Gerard M; Decamp M; Mathieu M; Morin G; Jedraszak G; Bilan F; Gilbert-Dussardier B; Fauvert D; Roume J; Cormier-Daire V; Caumes R; Puechberty J; Genevieve D; Sarda P; Pinson L; Blanchet P; Lemeur N; Sheth F; Manouvrier-Hanu S; Andrieux J
Eur J Med Genet; 2015 Mar; 58(3):140-7. PubMed ID: 25596525
[TBL] [Abstract][Full Text] [Related]
5. Clinical features and magnesium levels: Novel insights in 15q11.2 BP1-BP2 copy number variants.
Meossi C; Carrer A; Ciaccio C; Estienne M; Silipigni R; Sciacca FL; Pantaleoni C; D'Arrigo S; Milani D
J Intellect Disabil Res; 2023 Jul; 67(7):679-689. PubMed ID: 37129092
[TBL] [Abstract][Full Text] [Related]
6. Genomic, Clinical, and Behavioral Characterization of 15q11.2 BP1-BP2 Deletion (Burnside-Butler) Syndrome in Five Families.
Baldwin I; Shafer RL; Hossain WA; Gunewardena S; Veatch OJ; Mosconi MW; Butler MG
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33562221
[TBL] [Abstract][Full Text] [Related]
7. No signs of neurodegenerative effects in 15q11.2 BP1-BP2 copy number variant carriers in the UK Biobank.
Boen R; Kaufmann T; Frei O; van der Meer D; Djurovic S; Andreassen OA; Selmer KK; Alnæs D; Sønderby IE
Transl Psychiatry; 2023 Feb; 13(1):61. PubMed ID: 36807331
[TBL] [Abstract][Full Text] [Related]
8. 15q11.2 proximal imbalances associated with a diverse array of neuropsychiatric disorders and mild dysmorphic features.
Abdelmoity AT; LePichon JB; Nyp SS; Soden SE; Daniel CA; Yu S
J Dev Behav Pediatr; 2012 Sep; 33(7):570-6. PubMed ID: 22922608
[TBL] [Abstract][Full Text] [Related]
9. Recurrent 15q11.2 BP1-BP2 microdeletions and microduplications in the etiology of neurodevelopmental disorders.
Picinelli C; Lintas C; Piras IS; Gabriele S; Sacco R; Brogna C; Persico AM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1088-1098. PubMed ID: 27566550
[TBL] [Abstract][Full Text] [Related]
10. Reciprocal White Matter Changes Associated With Copy Number Variation at 15q11.2 BP1-BP2: A Diffusion Tensor Imaging Study.
Silva AI; Ulfarsson MO; Stefansson H; Gustafsson O; Walters GB; Linden DEJ; Wilkinson LS; Drakesmith M; Owen MJ; Hall J; Stefansson K
Biol Psychiatry; 2019 Apr; 85(7):563-572. PubMed ID: 30583851
[TBL] [Abstract][Full Text] [Related]
11. Deletion of 15q11.2(BP1-BP2) region: further evidence for lack of phenotypic specificity in a pediatric population.
Hashemi B; Bassett A; Chitayat D; Chong K; Feldman M; Flanagan J; Goobie S; Kawamura A; Lowther C; Prasad C; Siu V; So J; Tung S; Speevak M; Stavropoulos DJ; Carter MT
Am J Med Genet A; 2015 Sep; 167A(9):2098-102. PubMed ID: 25946043
[TBL] [Abstract][Full Text] [Related]
12. Beyond the Global Brain Differences: Intraindividual Variability Differences in 1q21.1 Distal and 15q11.2 BP1-BP2 Deletion Carriers.
Boen R; Kaufmann T; van der Meer D; Frei O; Agartz I; Ames D; Andersson M; Armstrong NJ; Artiges E; Atkins JR; Bauer J; Benedetti F; Boomsma DI; Brodaty H; Brosch K; Buckner RL; Cairns MJ; Calhoun V; Caspers S; Cichon S; Corvin AP; Crespo-Facorro B; Dannlowski U; David FS; de Geus EJC; de Zubicaray GI; Desrivières S; Doherty JL; Donohoe G; Ehrlich S; Eising E; Espeseth T; Fisher SE; Forstner AJ; Fortaner-Uyà L; Frouin V; Fukunaga M; Ge T; Glahn DC; Goltermann J; Grabe HJ; Green MJ; Groenewold NA; Grotegerd D; Grøntvedt GR; Hahn T; Hashimoto R; Hehir-Kwa JY; Henskens FA; Holmes AJ; Håberg AK; Haavik J; Jacquemont S; Jansen A; Jockwitz C; Jönsson EG; Kikuchi M; Kircher T; Kumar K; Le Hellard S; Leu C; Linden DE; Liu J; Loughnan R; Mather KA; McMahon KL; McRae AF; Medland SE; Meinert S; Moreau CA; Morris DW; Mowry BJ; Mühleisen TW; Nenadić I; Nöthen MM; Nyberg L; Ophoff RA; Owen MJ; Pantelis C; Paolini M; Paus T; Pausova Z; Persson K; Quidé Y; Marques TR; Sachdev PS; Sando SB; Schall U; Scott RJ; Selbæk G; Shumskaya E; Silva AI; Sisodiya SM; Stein F; Stein DJ; Straube B; Streit F; Strike LT; Teumer A; Teutenberg L; Thalamuthu A; Tooney PA; Tordesillas-Gutierrez D; Trollor JN; van 't Ent D; van den Bree MBM; van Haren NEM; Vázquez-Bourgon J; Völzke H; Wen W; Wittfeld K; Ching CRK; Westlye LT; Thompson PM; Bearden CE; Selmer KK; Alnæs D; Andreassen OA; Sønderby IE;
Biol Psychiatry; 2024 Jan; 95(2):147-160. PubMed ID: 37661008
[TBL] [Abstract][Full Text] [Related]
13. Association of congenital cardiovascular malformation and neuropsychiatric phenotypes with 15q11.2 (BP1-BP2) deletion in the UK Biobank.
Williams SG; Nakev A; Guo H; Frain S; Tenin G; Liakhovitskaia A; Saha P; Priest JR; Hentges KE; Keavney BD
Eur J Hum Genet; 2020 Sep; 28(9):1265-1273. PubMed ID: 32327713
[TBL] [Abstract][Full Text] [Related]
14. Treatment-resistant psychotic symptoms and the 15q11.2 BP1-BP2 (Burnside-Butler) deletion syndrome: case report and review of the literature.
Farrell M; Lichtenstein M; Harner MK; Crowley JJ; Filmyer DM; Lázaro-Muñoz G; Dietterich TE; Bruno LM; Shaughnessy RA; Biondi TF; Burkholder S; Donmoyer J; Berg JS; Szatkiewicz J; Sullivan PF; Josiassen RC
Transl Psychiatry; 2020 Jan; 10(1):42. PubMed ID: 32066678
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic association of 15q11.2 CNVs of the region of breakpoints 1-2 (BP1-BP2) in a large cohort of samples referred for genetic diagnosis.
Mohan KN; Cao Y; Pham J; Cheung SW; Hoffner L; Ou ZZ; Surti U; Cook EH; Beaudet AL
J Hum Genet; 2019 Mar; 64(3):253-255. PubMed ID: 30542208
[TBL] [Abstract][Full Text] [Related]
16. Analysis of Diffusion Tensor Imaging Data From the UK Biobank Confirms Dosage Effect of 15q11.2 Copy Number Variation on White Matter and Shows Association With Cognition.
Silva AI; Kirov G; Kendall KM; Bracher-Smith M; Wilkinson LS; Hall J; Ulfarsson MO; Walters GB; Stefansson H; Stefansson K; Linden DEJ; Caseras X
Biol Psychiatry; 2021 Sep; 90(5):307-316. PubMed ID: 33931204
[TBL] [Abstract][Full Text] [Related]
17. Familial transmission of recurrent 15q11.2 (BP1-BP2) microdeletion encompassing NIPA1, NIPA2, CYFIP1, and TUBGCP5 associated with phenotypic variability in developmental, speech, and motor delay.
Chen CP; Lin SP; Lee CL; Chern SR; Wu PS; Chen YN; Chen SW; Wang W
Taiwan J Obstet Gynecol; 2017 Feb; 56(1):93-97. PubMed ID: 28254235
[TBL] [Abstract][Full Text] [Related]
18. Magnesium Supplement and the 15q11.2 BP1-BP2 Microdeletion (Burnside-Butler) Syndrome: A Potential Treatment?
Butler MG
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31207912
[TBL] [Abstract][Full Text] [Related]
19. The 15q11.2 BP1-BP2 Microdeletion (
Rafi SK; Butler MG
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32384786
[TBL] [Abstract][Full Text] [Related]
20. Adverse Perinatal and Early Life Outcomes following 15q11.2 CNV Diagnosis.
Chu FC; Shaw SW; Lee CH; Lo LM; Hsu JJ; Hung TH
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
